MENU

ELTX Elicio Therapeutics Forecast, Technical & Fundamental Analysis

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

ELTX is expected to report earnings to rise 36.77% to -41 cents per share on March 26

Elicio Therapeutics ELTX Stock Earnings Reports
Q4'26
Est.
$-0.41
Q3'26
Beat
by $0.12
Q2'26
Beat
by $0.11
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.19
The last earnings report on November 05 showed earnings per share of -30 cents, beating the estimate of -41 cents. With 0.00 shares outstanding, the current market capitalization sits at 39.69M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PM196.352.10
+1.08%
Philip Morris International
FR55.260.30
+0.55%
First Industrial Realty Trust
SVV9.91-0.16
-1.59%
Savers Value Village
SMJF1.40-0.05
-3.45%
SMJ International Holdings Inc
CPS18.93-0.81
-4.10%
Cooper-Standard Automotive

ELTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELTX has been loosely correlated with CNTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ELTX jumps, then CNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
+1.24%
CNTX - ELTX
42%
Loosely correlated
+15.56%
PRME - ELTX
35%
Loosely correlated
+10.26%
JANX - ELTX
34%
Loosely correlated
+2.91%
TRAW - ELTX
33%
Loosely correlated
+11.11%
IMVT - ELTX
32%
Poorly correlated
+3.72%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
33
Web
https://www.elicio.com